vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and MOVING iMAGE TECHNOLOGIES INC. (MITQ). Click either name above to swap in a different company.

IMMUCELL CORP is the larger business by last-quarter revenue ($5.5M vs $3.8M, roughly 1.5× MOVING iMAGE TECHNOLOGIES INC.). IMMUCELL CORP runs the higher net margin — -2.5% vs -10.2%, a 7.7% gap on every dollar of revenue. On growth, MOVING iMAGE TECHNOLOGIES INC. posted the faster year-over-year revenue change (10.2% vs -8.4%). Over the past eight quarters, MOVING iMAGE TECHNOLOGIES INC.'s revenue compounded faster (7.8% CAGR vs 3.9%).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

ICCC vs MITQ — Head-to-Head

Bigger by revenue
ICCC
ICCC
1.5× larger
ICCC
$5.5M
$3.8M
MITQ
Growing faster (revenue YoY)
MITQ
MITQ
+18.6% gap
MITQ
10.2%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
7.7% more per $
ICCC
-2.5%
-10.2%
MITQ
Faster 2-yr revenue CAGR
MITQ
MITQ
Annualised
MITQ
7.8%
3.9%
ICCC

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ICCC
ICCC
MITQ
MITQ
Revenue
$5.5M
$3.8M
Net Profit
$-139.7K
$-388.0K
Gross Margin
42.9%
30.7%
Operating Margin
0.4%
-10.8%
Net Margin
-2.5%
-10.2%
Revenue YoY
-8.4%
10.2%
Net Profit YoY
80.1%
26.4%
EPS (diluted)
$-0.02
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
MITQ
MITQ
Q4 25
$3.8M
Q3 25
$5.5M
$5.6M
Q2 25
$6.4M
Q1 25
$8.1M
$3.6M
Q4 24
$7.8M
$3.4M
Q3 24
$6.0M
$5.3M
Q2 24
$5.5M
$6.3M
Q1 24
$7.3M
$3.9M
Net Profit
ICCC
ICCC
MITQ
MITQ
Q4 25
$-388.0K
Q3 25
$-139.7K
$509.0K
Q2 25
$501.9K
Q1 25
$1.4M
$-240.0K
Q4 24
$-527.0K
Q3 24
$-701.7K
$-25.0K
Q2 24
$-1.5M
$-416.0K
Q1 24
$-437.9K
$-601.0K
Gross Margin
ICCC
ICCC
MITQ
MITQ
Q4 25
30.7%
Q3 25
42.9%
30.0%
Q2 25
43.7%
Q1 25
41.6%
29.8%
Q4 24
36.5%
27.2%
Q3 24
26.3%
26.1%
Q2 24
22.5%
22.5%
Q1 24
31.6%
17.4%
Operating Margin
ICCC
ICCC
MITQ
MITQ
Q4 25
-10.8%
Q3 25
0.4%
6.3%
Q2 25
8.8%
Q1 25
13.9%
-7.6%
Q4 24
8.0%
-16.3%
Q3 24
-9.6%
-1.3%
Q2 24
-25.3%
-7.3%
Q1 24
-4.1%
-16.7%
Net Margin
ICCC
ICCC
MITQ
MITQ
Q4 25
-10.2%
Q3 25
-2.5%
9.1%
Q2 25
7.8%
Q1 25
17.9%
-6.7%
Q4 24
-15.3%
Q3 24
-11.7%
-0.5%
Q2 24
-28.0%
-6.6%
Q1 24
-6.0%
-15.4%
EPS (diluted)
ICCC
ICCC
MITQ
MITQ
Q4 25
$-0.04
Q3 25
$-0.02
$0.05
Q2 25
$0.06
Q1 25
$0.16
$-0.02
Q4 24
$0.09
$-0.05
Q3 24
$-0.09
$0.00
Q2 24
$-0.20
$-0.04
Q1 24
$-0.06
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
MITQ
MITQ
Cash + ST InvestmentsLiquidity on hand
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$5.0M
Total Assets
$45.7M
$9.5M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
$3.9M
Q2 25
Q1 25
Q4 24
$3.8M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Total Debt
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
ICCC
ICCC
MITQ
MITQ
Q4 25
$5.0M
Q3 25
$29.8M
$5.4M
Q2 25
$29.9M
Q1 25
$29.0M
$5.0M
Q4 24
$27.5M
$5.2M
Q3 24
$26.4M
$5.7M
Q2 24
$23.5M
$5.7M
Q1 24
$24.6M
$6.3M
Total Assets
ICCC
ICCC
MITQ
MITQ
Q4 25
$9.5M
Q3 25
$45.7M
$11.3M
Q2 25
$46.7M
Q1 25
$45.6M
$11.2M
Q4 24
$45.1M
$10.0M
Q3 24
$44.4M
$10.7M
Q2 24
$41.9M
$10.5M
Q1 24
$43.1M
$12.7M
Debt / Equity
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
MITQ
MITQ
Operating Cash FlowLast quarter
$-1.2M
$-1.6M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-32.3%
Capex IntensityCapex / Revenue
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
MITQ
MITQ
Q4 25
$-1.6M
Q3 25
$-1.2M
$-167.0K
Q2 25
$1.6M
Q1 25
$1.6M
$53.0K
Q4 24
$-3.1K
$70.0K
Q3 24
$-639.3K
$-32.0K
Q2 24
$581.8K
$-472.0K
Q1 24
$418.5K
$1.0M
Free Cash Flow
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
$-1.8M
Q2 25
$1.4M
Q1 25
$1.2M
Q4 24
$-199.3K
Q3 24
$-727.7K
Q2 24
$471.0K
Q1 24
$348.1K
FCF Margin
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
-32.3%
Q2 25
22.4%
Q1 25
15.4%
Q4 24
-2.6%
Q3 24
-12.1%
Q2 24
8.6%
Q1 24
4.8%
Capex Intensity
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
10.8%
Q2 25
2.4%
Q1 25
4.1%
Q4 24
2.5%
Q3 24
1.5%
Q2 24
2.0%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
ICCC
ICCC
MITQ
MITQ
Q4 25
Q3 25
-0.33×
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons